Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.

× No keyword cloud information.

17 in total

1. Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.

Authors: D P Reitberg; T J Whall; M Chung; D Blickens; H Swarz; J Arnold
Journal: Antimicrob Agents Chemother Date: 1988-01 Impact factor: 5.191

2. Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors: R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191

3. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.

Authors: B Kemmerich; H Lode; G Belmega; T Jendroschek; K Borner; P Koeppe
Journal: Antimicrob Agents Chemother Date: 1983-03 Impact factor: 5.191

4. Decreased extrarenal clearance of cefoperazone in hepatocellular diseases.

Authors: B Cochet; J Belaieff; A F Allaz; M Rudhardt; L Balant; J Fabre
Journal: Br J Clin Pharmacol Date: 1981-04 Impact factor: 4.335

Review 5. Cephalosporins in urinary tract infection.

Authors: L O Gentry
Journal: Drugs Date: 1987 Impact factor: 9.546

Review 6. Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors: W L St Peter; K A Redic-Kill; C E Halstenson
Journal: Clin Pharmacokinet Date: 1992-03 Impact factor: 6.447

7. Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.

Authors: B R Meyers; M H Mendelson; R G Deeter; E Srulevitch-Chin; M T Sarni; S Z Hirschman
Journal: Antimicrob Agents Chemother Date: 1987-06 Impact factor: 5.191

8. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.

Authors: D P Reitberg; D A Marble; R W Schultz; T J Whall; J J Schentag
Journal: Antimicrob Agents Chemother Date: 1988-04 Impact factor: 5.191

9. Cefoperazone pharmacokinetics in preterm infants.

Authors: J A Bosso; G M Chan; J M Matsen
Journal: Antimicrob Agents Chemother Date: 1983-03 Impact factor: 5.191

Review 10. Clinical pharmacokinetics of the third generation cephalosporins.

Authors: L Balant; P Dayer; R Auckenthaler
Journal: Clin Pharmacokinet Date: 1985 Mar-Apr Impact factor: 6.447